Duwat, Nilda B.

HRN: 26-57-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
CEFTRIAXONE 1G (VIAL)
01/24/2025
01/31/2025
IVT
2g
OD
CAP
Waiting Final Action 
02/03/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/03/2025
02/07/2025
IV
2.25 G
OD
Infectious Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: